the rest of the color generation system, stabilizers, and antibody to DNP; and a solution of DNP-FAD in n-propanol; This preparation permits effective antibody binding, and prevents premature interaction of immunoassay components. A quantitative color response to concentrations of DNP-caproate in the range of 1 to 8 tmol/L was demonstrated with these reagent strips. Prototype to increasing ligand concentration, allowing the immunoassay to be monitored with the unaided eye or with a reflectance spectrophotometer. 
MaterIals and Methods

Reagents
Procedures
Synthesis of FAD conjugates.
The synthesis of theophylline-FAD and flavin N6-(6-aminohexyl)adenine dinucleotide has been described (3). 
System into a Reagent-Strip Format
In this work, we used a model PGLIA system in which DNP-FAD served as conjugate, and DNP-caproate as the iigand being assayed. The PGLIA system was chosen because it had been well characterized (3) , and because the competitive-binding assay is monitored colorimetrically.
The development of color in proportion to ligand concentration would permit the results of reagent strip immunoassays to be obtained either visually or instrumentally.
One disadvantage of the system, however, at first appeared to be the instability of the apoenzyme, which is the central component in the colorgenerationsystem. Glucose oxidase apoenzyme is most stable at 4#{176}C in buffers of neutral pH containing glycerol; deviations from these conditions result in losses in reconstitutable activity (3). Consequently, initial efforts to develop a reagentstrip system focused upon stabilizing the apoenzyme so that filter paper could be impregnated with reagent solutions and dried in warm air without incurring unacceptable losses in reconstitutable activity. We found that a combination of PVA and BSA could stabilize glucose oxidase apoenzyme in reagent strips. As illustrated in Table 1 , filter paper was impregnated with apoenzyme, the essential components of the color generation system (peroxidase, TMB, buffer, glucose), and PVA and (or) BSA. The reconstitutable activity was determined by pipetting a quantity of DNP-FAD in excess of theoretically available apoenzyme binding sites onto the strips, and comparing the color generated with that found in strips where no reconstitution could take place (strips wetted with water alone). As shown by the E values, very little activity is present in the absence of stabilizers, and PVA is a better stabilizing agent than BSA. In addition, the combination of PVA and BSA results in more color production, and thus, more reconstitutable activity, then either one alone. The concentrations of BSA and PVA listed in Table 1 were best used at the drying temperature of 90#{176}C. When a lower drying temperature was used (50 #{176}C), similar stabilization could be achieved at the same BSA concentration in combination with less PVA (5 g/L).
To determine if BSA and PVA have other effects on the color generation system, we prepared reagent strips containing these stabilizers but lackingapoenzyme. Color generation was initiated by applying solutions of hydrogen peroxide to the strips. We observed no change in color generation in the presence of the stabilizers, indicating that PVA and BSA have no effect on either peroxidase or TMB. Thus, the effect of these two materials appears to be specifically apoenzyme stabilization.
To determine the amount of apoenzyme activity actually present in reagent strips containing PVA and BSA, we pipetted solutions containing known apoenzyme activities onto
We used this assay system to determine the ability of antiserum to inhibit apoenzyme reconstitution with the appropriate conjugate. Conjugate and antiserum were added to the reaction mixture, followed immediately by apoenzyme. Reconstitution of apoenzyme and the measurement of activity were simultaneous. We recorded the change in absorbance at 520 nm during the first 2 mm.
Preparation of reagent strips. To study the color generation system and antibody binding reactions, we first impregnated the filter paper (no. 205; Eaton and Dikeman Co., Mt. Holly Springs, PA 17065) with a solution of TMB in acetone (2 mmol/L). The paper was dried at 90#{176}C for 1-2 mm, and then impregnated with an aqueous solution of pH 6.4 Tris-glutamate-citrate buffer (per liter, 18 mmol of Tris, 13 mmol of glutamic acid, 1.5 mmol of citric acid) containing, per liter, 0.1 mol of glucose, 19 kU of peroxidase, 0.5 g of BSA, lOg of PVA, glucose oxidase apoenzyme (1-2 imol FAD binding sites), and antibody solution (0.14-0.28 mL/mL of impregnation solution). Enough antibody was added to provide, as determined by experiments with these reagents in solution, 70-80% inhibition of apoenzyme reconstitution in reagent strips. The papers were again dried at 90 #{176}C for 6-7 mm.
In experiments in which FAD conjugates were impregnated into reagent papers containing the other immunoassay components, we used a slightly different procedure. Filter paper (S-22; Buckeye Cellulose Corp., Memphis, TN 38108) was impregnated with a solution of 5 mmol of TMB and 1 g of ON-870 per liter of acetone. After drying the papers at 50#{176}C for 1 mm, we impregnated them with an aqueous solution as described above, except that the buffer was 0.2 mol/L Tnisglutamate, pH 6.4, and the PVA concentration was 5 g/L. Papers were then dried at 50 #{176}C for 12-15 mm, after which they received a fmal impregnation with a solution of conjugate in n-propanol. The concentrations used were: DNP-FAD, 2 Mmol/L; theophylline-FAD or phenytoin-FAD, 0.5 smol/L. In some experiments, GAFQUAT 734 was included in the n-propanol solutions: 5 g/L with theophylline-FAD and 1 g/L with phenytoin-FAD.
After the third impregnation, papers were dried at 50 #{176}C for 4-5 mm. All dryings were done in a mechanical convection oven. Impregnated papers were cut into 0.5-cm squares and converted to reagent strips by mounting them with doubleface adhesive tape (Minnesota Mining & Manufacturing Co., St. Paul, MN 55101) at one end of polystyrene strips measuring 0.5 X 8.3 cm.
Evaluation of reagent strips.
Solutions containing analyte or conjugate were pipetted onto the reagent-bearing area of the reagent strip. In some experiments, the reagent strips were dipped into the solutions and rapidly withdrawn, to examine behavior in a dip-and-read mode. After incubating the strips for 2-6 mm at 24-26 #{176}C, we obtained the reflectance spectra by using a computer-interfaced rapid-scanning reflectance spectrophotometer equipped with an integrating sphere, as previously described (8) . The reflectance values at 660 nm, which is the visible-range absorption maximum of the blue oxidized form of TMB (9), were used to calculate the ratio K/S according to Kubelka and Munk (10) . The ratio K/S is a function of the concentration of the chromophore, and is thus proportional to the ligand concentration in the immunoassay. In some experiments, the tristimulus values obtained from the scanner were used to calculate the color difference (SE) between reagent strips, according to the CIELAB convention (11) . This system is used in the color industry to quantitate the perceived difference between two colors, which is proportional to iE. One color difference unit is approximately the minimum difference that can be perceived by the unaided eye.
All data are averaged from duplicate or triplicate determinations. Mmol/L DNP-FAD and the same strips wetted wIth 15 MLof distilled water. Incttwtlon time was 5 mm. The hee types of strips had the same color (off-white) at the beginning of the reaction. reagent strips lacking apoenzyme, along with solutions containing conjugate.
Using reflectance data from these strips, we prepared a standard curve relating apoenzyme activity to color development. Apoenzyme activity in strips impregnated with apoenzyme was determined by comparing with the standard curve the color development obtained upon wetting with conjugate solution. One problem with such an experiment is that dissolution kinetics must be ignored. A finite time is required for impregnated apoenyme to dissolve upon wetting of a reagent strip before reconstitution with DNP-FAD can begin. Dissolution of apoenzyme, however, was not a factor in the preparation of the standard curve. For this reason, we expected to obtain only a minimum estimate of apoenzyme activity from these experiments.
Nevertheless, the experiments showed apoenzyme activity in reagent strips containing PVA and BSA to be 60-95% of that theoretically possible, the wide range probably being due to small variations in environmental conditions. The retention of high apo#{233}nzyme activity.in reagent strips therefore allowed us to investigate the feasibility of assembling the other components of the immunoassay into a reagent strip format.
Incorporation of Antibody into the Reagent-Strip System
We investigated the feasibility of placing apoenzyme and antibody together in the same reagent area, the simplest method for incorporating antibody into the reagent system. Table 2 presents the resulta of an experiment in which we examined the ability of antibody tO DNP to inhibit reconsti-K/S DNP.CAPROATE. mnol/I. Fig. 3 . Reversal of inhibition in reagent strips by DNP-caproate SolutIons (15 ML)of DNP-FAD (1 MmoI/L) containing the Indicated concentration of DNP-caproate were pipetted onto reagent strips impregeated with components of the color-generation system and antibody to DNP. After 6 mm, the strips were analyzed as described in text tution of apoenzyme in reagent strips. Filter paper was impregnated with the components of the colorgenerationsystem and with an amount of antibody that should have caused near-complete inhibition. As shown, very little color developed in these strips when DNP-FAD was applied as compared with that found with strips containing no antibody. No inhibition was found with strips impregnated with normal serum, indicating that inhibition of reconstitution in the reagent strip is due specifically to an interaction between antibody and DNP-FAD conjugate.
With the antibody binding appearing to proceed efficiently, we attempted to reverse antibody inhibition with DNP-caproate, and thus to demonstrate a competitive binding assay in a reagent strip format. Such an experiment is shown in Figure 3 . Reagent strips containing the color-generation system and antibody to DNP were wetted with solutions containing a fixed concentration of DNP-FAD, and increasing concentrations of DNP-caproate. The increase in K/S observed with increasing DNP-caproate concentration is indicative of increased formation of blue color in response to reversal of inhibition. The perceptible difference in color (i.E) between reagent strips receiving different concentrations of DNP-caproate indicates that various concentrations can be visually discriminated.
Although these reagent strips were impregnated with only part of the immunoassay system (color generation system and antibody), the experiment shows that PGLIA can function in a reagent-strip format, with the potential for visual monitoring of this type of assay with the unaided eye.
Preparation of a Complete Reagent Strip
Containing All of the Immunoassay Components
The incomplete strip format illustrated in Figure 3 could, with further development, provide a practical means for assaying for clinically important compounds in biological fluids. However, reagent manipulations would be required, as conjugate would have to be added to the sample before the sample was applied to the reagent strip. To eliminate this operation, we sought to integrate conjugate into the reagentstrip immunoassay system. The ultimate objective was a device containing conjugate, antibody, and the color-generation system, all in the same reagent area.
One major obstacle we encountered in the present study was the need to prevent premature interaction of conjugate with apoenzyme and antibody on the reagent strips. Binding of Reagent strips containingthe color-generation system, theophylline-FAD, and antIbody to theophyllmne, were prepared as described intext, except that conjugate was Impregnated as an n-propanol solution with (A) or without (#{149})
GAFQUAT 734(5 g/L). SolutIons (15 ML)contaInIng the Indicated concentration of theophylline were plpetted onto the strIps, and the strips were analyzed with the Rapid Scanner 2 mln later conjugate must be controlled so that it occurs only when reagent strips are wetted with solution containing the ligand being assayed, not when the reagent strip system is being assembled. An approach that satisfied this requirement was to impregnate reagent papers already containing antibody and the color-generation system with a solution of conjugate in n-propanol.
Presumably, premature interaction was prevented because of the insolubility of apoenzyme and antibody in this solvent. Figure 4 illustrates the color response obtained when reagent strips prepared in this manner were wetted with solutions containing DNP-caproate. Increasing concentrations of DNP-caproate clearly result in increased color, indicating that a complete PGLIA reagent strip system has been successfully assembled. In addition, the perceived color difference (.E) between concentrations of DNP-caproate indicates that direct visual monitoring of the immunoassay is possible, as was confirmed by observation.
The results presented in Figure 4 were obtained by dipping the strips into solutions of DNP-caproate instead of pipetting the solutions onto the strips. This demonstrates the feasibility of a dip-and-read mode for reagent-strip immunoassay.
Extension to Compounds of Clinical Importance-
Theophylline and Phenytoin
We sought to determine ifthe principlesevolved with the model system could be applied to the development of complete PGLIA reagent strips for ligands having clinical significance.
Accordingly, theophylline-FAD and antibody to theophyffine were substituted for the corresponding reagents in the complete DNP reagent strip system. The color developed in response to theophylline in reagent strips thus prepared is shown in Figure 5 . Here, the largest color change occurred between 0 and 1 Mmol/L drug concentration. A simple substitution of reagents as above can produce a PGLIA reagent strip that responds to theophylline. Figure 5 also illustrates an improvement that was discovered at this stage of the work. We became aware that there was some loss of apoenzyme activity during impregnation with solutions of n-propanoL This loss, which was not quantitated, is partly prevented by including GAFQUAT#{174} 734 in the apropanol solution. This polymer, which contains vinylpyrrolidone residues as well as quaternary amine groups, appears to provide additional stabilization for the apoenzyme, and results in a more intense blue color ( Figure 5) . The mechanism by which this occurs is unknown, although an ionic-binding interaction that prevents denaturation of the apoenzyme could be involved. GAFQUAT 734 had no effect on the rest of the color generation system, the antibody-binding reaction, or the rate of reconstitution with conjugate. Complete PGLIA reagent strips for phenytoin were also prepared by suitable reagent substitution as above. Figure 6 illustrates the color development obtained with these strips in response to phenytoin when used in a dip-and-read mode. The color changes are larger than those encountered in the previous PGLIA reagent strips, mainly because reconstitution of apoenzyme with phenytoin-FAD proceeds more rapidly than with other FAD conjugates (P. A. Rupchock, unpublished observations). The data indicate that PGLIA strip assays for phenytoin could be monitored readily by the unaided eye.
The successful assembly of PGLIA reagent strips for theophylline and phenytoin indicates that antibody-binding kinetics and the solubility properties of apoenzyme and antibody can also be utilized advantageously in the preparation of practical PGLIA strip systems.
The reagent-strip homogeneous immunoassay system that we have developed combines convenience, simplicity, and rapid results, and appears to be generally applicable to compounds of clinical importance. This format can be used with instruments, and also has potential for practical use in a dip-and-read mode with interpretation of the results by the unaided eye. We hope that this technology, when fully developed, will greatly facilitate the performance of immunoassays in the clinical laboratory.
